bb3497 has been researched along with amikacin in 1 studies
| Studies (bb3497) | Trials (bb3497) | Recent Studies (post-2010) (bb3497) | Studies (amikacin) | Trials (amikacin) | Recent Studies (post-2010) (amikacin) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 4,739 | 485 | 1,316 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canaan, S; Cavalier, JF; Magrioti, V; Mallick, I; Mavrikaki, V; Pagonis, A; Poncin, I | 1 |
1 other study(ies) available for bb3497 and amikacin
| Article | Year |
|---|---|
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
Topics: Animals; Anti-Bacterial Agents; Hydrazines; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |